ARCHIVES

J&J To Eliminate Its Ortho Biotech Unit As FDA Considers Further Limits On ESAs.

This article is from The Cancer Letter archive.

Vol. 34 No. 17 | May 2, 2008

Download PDF Visit The Full Archive

Related Articles

NCI Would Get More Money For AIDs Under Heckler Proposal, But Most Would Come Out Of Construction

August 2, 1985

CMS will pay oncologists to report adherence to practice guidelines.

November 4, 2005

In Brief: NCI, OMB Heading For November Confrontation Over Hawaii, Papanicolaou Construction Funds

October 17, 1975

CPRIT Executive Director Bill Gimson Is Out As Scandal Grows, Investigations Begin

December 14, 2012

Prostate Cancer Prevention Trial Begins At 222 U.S. Sites

October 22, 1993

President’s Cancer Panel Road Show Producers Ideas For Improving Finding Mechanisms; NCI Buys Some

July 23, 1982